Furthermore, while the overall comparison between immediate discontinuation (Group A) and later withdrawal groups (Groups B and C) did not reach statistical significance, the trend toward higher ALT exacerbation rates in Group A ( P = 0.062) highlights potential risks associated with early discontinuation, and prolonged TDF therapy may provide increasing protection against severe liver inflammation.
← all excerpts
Impact of stopping Tenofovir disoproxil fumarate at various times on elevated postpartum ALT levels and breastfeeding in pregnant women with chronic hepatitis B: a prospective observational cohort study.
1
0.0620
0.0620